Photo from wikipedia
D‐dimer is a marker of fibrin degradation that reflects intravascular coagulation. Therefore, plasma concentrations of D‐dimer might predict thromboembolic risk and rivaroxaban treatment effect. The aims of this study were… Click to show full abstract
D‐dimer is a marker of fibrin degradation that reflects intravascular coagulation. Therefore, plasma concentrations of D‐dimer might predict thromboembolic risk and rivaroxaban treatment effect. The aims of this study were to investigate the association between D‐dimer levels and the risk of stroke and other thrombotic, bleeding and fatal events, and whether D‐dimer concentrations could predict rivaroxaban 2.5 mg twice daily (vs. placebo) effect in patients enrolled in the COMMANDER‐HF trial who were in sinus rhythm, had heart failure with reduced ejection fraction and coronary artery disease.
Journal Title: European Journal of Heart Failure
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!